Walvax Biotechnology Co., Ltd.

SZSE:300142.SZ

21.88 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20232022202120202019201820172016201520142013201220112010200920082007
Operating Activities:
Net Income 419.39938.226601.3521,211.187194.1361,062.691-558.24330.02-924.65396.7054.882225.358207.538154.41776.33134.77.425
Depreciation & Amortization 333.335264.931143.837123.94876.63115.714109.406102.44973.115117.36126.33238.36515.55811.27212.42210.3843.105
Deferred Income Tax -0.83229.545-6.5361.704-88.351-103.019-25.956-17.52411.61900000000
Stock Based Compensation 0-38.79184.75179.28167.49819.10300153.109029.144.54500000
Change In Working Capital -193.071-315.404-249.022-908.628-137.255-139.351195.958-323.625-136.34512.51-352.707-213.872-147.085-87.875-28.916-58.68511.086
Accounts Receivables 535.703-1,240.976-614.652-1,495.485-72.909-215.434-15.543219.389-126.708-75.217-171.42-150.14700000
Inventory -134.901-178.789-390.032-170.511-76.766-25.641-55.599-10.449-3.362219.359-228.5086.699-32.547-13.746-12.328-8.875-7.257
Accounts Payables -593.8731,074.817762.197755.664100.771204.743293.055-515.04-17.89400000000
Other Working Capital 029.545-6.5361.704-88.351-113.711251.557-313.175-132.983-206.849-124.199-220.571-114.538-74.128-16.588-49.81118.343
Other Non Cash Items 1,441.419245.401130.895-393.298-50.64-1,104.282195.834101.218918.469-292.50899.76128.5315.9688.89822.3477.90610.229
Operating Cash Flow 1,140.5011,201.491705.277114.19362.017-65.228-57.044-89.937-69.413-65.933-121.73278.38191.97886.71182.184-5.69531.845
Investing Activities:
Investments In Property Plant And Equipment -945.516-1,091.177-1,103.484-407.131-351.823-227.322-331.062-250.236-264.748-240.393-389.671-355.867-197.56-164.814-74.754-29.39-18.256
Acquisitions Net 145.237149.38675.6875567.4811,188.961287.245250.778-288.21212.512-727.324-524.09500000
Purchases Of Investments -100-62.462-407.558-26.5-389-1-6.8-54.775-0.1-167.90-11.700-100
Sales Maturities Of Investments 6.7846.263109.3835.2193.63946.0653.97627.113183.5972.1370.12000000
Other Investing Activites -6.7840.3423.7344.4710.20.43226.40589.708-27.024-224.474-144.354-185.8610.0020.006-2.49-29.390.08
Investing Cash Flow -810.278-935.186-977.15-730192.996619.137-14.436110.563-451.16-250.318-1,429.129-1,065.823-209.258-164.809-77.245-39.39-18.176
Financing Activities:
Debt Repayment -351.034-390-140-40-30-220-810-1,365-1,086-1,217.5-696.675-182.985-179-26-63-59-19.5
Common Stock Issued 0286.417000000000000000
Common Stock Repurchased -72.213-286.417000000000000000
Dividends Paid -15.993-43.242-78.309-30.869-46.123-4.455-34.313-126.127-154.672-173.968-98.307-58.755-48.904-4.501-3.83-3.952-2.041
Other Financing Activities -3.123534.9291,959.755286.808-261.955936.154702.2321,892.7052,169.6191,061.9682,153.213658.17-1.2152,369.072117.838105.226.246
Financing Cash Flow 232.19694.8181,736.44215.078-360.637711.699-142.081401.578928.947-329.4991,358.231416.43-229.1192,338.57251.00742.2484.705
Other Information:
Effect Of Forex Changes On Cash 2.2754.069-0.125-1.001-0.2091.601-0.5770.241-00-0000000
Net Change In Cash 491.06365.1921,464.443-401.73-105.8331,267.209-214.138422.445408.374-645.75-192.63-571.012-346.3992,260.47455.947-2.83718.374
Cash At End Of Period 4,364.5353,790.1693,424.9771,960.5352,362.2642,468.0971,200.8891,415.027992.582584.2081,229.9581,422.5891,993.6012,34079.52523.57826.415